Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01887
Species: Homo sapiens
Position : chr12:7439885-7440355
Year: 2023
Title: Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate adenocarcinoma
PMID:  37488417
MONDO: MONDO:0008315
Tissue: Prostate
Tissue Ontology ID: UBERON:0002367
Cell Source: LNCaP prostate cancer cell line
CVCL ID: CVCL_0395
Cell Type: prostate adenocarcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: CRISPR interference-based functional screen
High Throughput Method: CRISPRi screen, RNA-seq, ATAC-seq, ChIP-seq, Hi-C
Low Throughput Method: RT-qPCR, flow cytometry, FACS
About Target Gene
Target gene : NANOG
About TF
TF name : OCT4SOX2NANOG
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
SOX2 Deactivation of the beta-catenin transactivating complex reactome 42
SOX2 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
SOX2 POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation reactome 10
SOX2 Transcriptional regulation of pluripotent stem cells reactome 28
SOX2 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
SOX2 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
SOX2 Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 wikipathways 12
SOX2 Hs_Mesodermal_Commitment_Pathway_WP2857_87780 wikipathways 47
SOX2 Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
NANOG POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
NANOG POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation reactome 10
NANOG Transcriptional regulation of pluripotent stem cells reactome 28
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer